apixaban articles & resources on Made-in-China.com

FDA Accepted to Review Bristol-Myers and Pfizer's Eliquis Supplemental New Drug

Jul 12, 2013

The US FDA has accepted to review Bristol-Myers Squibb Company and Pfizer's Eliquis (apixaban) supplemental new drug application for prophylaxis of deep vein thrombosis (DVT) subsequent to hip or knee replacement surgery. The application ...

Tags: Drug Application, Medicine

Bristol-Myers Squibb and Pfizer Have Announced The US FDA's Approval for Eliquis

Jan 4, 2013

Bristol-Myers Squibb and Pfizer have announced the US FDA's approval for Eliquis (apixaban), used to reduce the risk of stroke and systemic embolism in patients with nonvalvular atrial fibrillation. In 2007, Pfizer and Bristol-Myers ...

Tags: US, FDA, Eliquis, patients, nonvalvular atrial fibrillation

Bristol-Myers Squibb and Pfizer Announced The Approval of Eliquis

Dec 28, 2012

Bristol-Myers Squibb and Pfizer have announced the approval of Eliquis (apixaban) anticoagulant for the prevention of ischemic stroke and systemic embolism in patients suffering from nonvalvular atrial fibrillation (NVAF) in Japan. The ...

Tags: Japan, approval, anticoagulant, subanalysis

The European Commission Has Cleared an Oral Anticoagulant, Eliquis

Nov 28, 2012

The European Commission has cleared an oral anticoagulant, Eliquis, developed by Bristol-Myers Squibb (BMS) and Pfizer. Eliquis 5mg, trade name of apixaban in Europe, is indicated as a twice-daily drug for preventing strokes and systemic ...

Tags: BMS-Pfizer Oral Anticoagulant, oral anticoagulant, Eliquis, apixaban

apixaban

FDA Accepted to Review Bristol-Myers and Pfizer's Eliquis Supplemental New Drug

Bristol-Myers Squibb and Pfizer Have Announced The US FDA's Approval for Eliquis

Bristol-Myers Squibb and Pfizer Announced The Approval of Eliquis

The European Commission Has Cleared an Oral Anticoagulant, Eliquis

Related Products